Cv1 - A Cost-Effectiveness Analysis of Muliti-Gene Pharmacogenetic Testing in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.032

Related search